Skip to main content
logo
Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.180
-0.060 (-4.84%)
At close: Sep 4, 2026, 4:00 PM EDT
1.200
+0.020 (1.69%)
After-hours: Sep 4, 2026, 7:57 PM EDT

Marker Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
11.3316.0719.1915.1111.7842.35
Cash & Short-Term Investments
11.3316.0719.1915.1111.7842.35
Cash Growth
8.31%-16.28%27.01%28.26%-72.18%98.34%
Other Receivables
1.621.372.351.032.40
Receivables
1.621.372.351.032.40
Prepaid Expenses
1.040.660.480.991.852.48
Restricted Cash
0.590.97---1.15
Other Current Assets
----0.59-
Total Current Assets
14.5919.0722.0217.1316.6245.98
Property, Plant & Equipment
-----22.15
Other Long-Term Assets
----17.8-
Total Assets
14.5919.0722.0217.1334.4268.14

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.590.791.070.961.15.14
Accrued Expenses
1.040.32.191.911.273.33
Current Portion of Leases
-----0.62
Current Unearned Revenue
0.590.97---1.15
Other Current Liabilities
0.20.20.20.215.412.66
Total Current Liabilities
2.422.273.463.077.7812.9
Long-Term Leases
-----11.25
Other Long-Term Liabilities
----7.04-
Total Liabilities
2.422.273.463.0714.8224.15

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.020.020.010.010.010.01
Additional Paid-In Capital
476.34475.96465.56450.33447.64442.1
Retained Earnings
-464.19-459.18-447.02-436.29-428.05-398.12
Shareholders' Equity
12.1716.818.5614.0519.643.99
Total Liabilities & Equity
14.5919.0722.0217.1334.4268.14

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
-----11.87
Net Cash (Debt)
11.3316.0719.1915.1111.7830.48
Net Cash Growth
8.31%-16.28%27.01%28.26%-61.35%235.15%
Net Cash Per Share
0.611.052.141.721.413.98
Filing Date Shares Outstanding
16.6716.6710.718.98.88.31
Total Common Shares Outstanding
16.6716.6710.718.898.418.31
Working Capital
12.1716.818.5614.058.8433.08
Book Value Per Share
0.731.011.731.582.335.29
Tangible Book Value
12.1716.818.5614.0519.643.99
Tangible Book Value Per Share
0.731.011.731.582.335.29
Machinery
-----9.66
Construction In Progress
-----2.23
Leasehold Improvements
-----3.17
SEC Filings: 10-K · 10-Q